An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A
Clinical trial NCT05849740 · RECRUITING
Trial details
- NCT number
- NCT05849740
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-22
- Primary completion
- 2027-04-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.